MITech Co (179290.KQ) Stock Price

MITech Co Price

CLOSED
4,635.00
​
Market closed

Revenue has compounded at 18.2% per year over the past 10 years to 67.15 B KRW. Earnings per share have grown at 37.9% per year over the last 10 years. MITech Co's net margin stands at 30.3%, up from 24.4% several years earlier. MITech Co currently offers a dividend yield of about 2.16%. The payout ratio is around 19% of earnings. The dividend has grown at 10.4% per year over the past 7 years. Analysts set a median price target of 13,260.00 KRW, implying 186.1% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

MITech Co stock price

Access this data via the Eulerpool API

MITech Co business model & stock analysis

M.I.Tech Co., Ltd. develops and manufactures non-vascular stent system. The company is headquartered in Pyeongtaek, Gyeonggi-Do and currently employs 140 full-time employees. The company went IPO on 2018-11-29. is a Korea-based company mainly engaged in the manufacturing and sale of stents. Stents include biliary, esophagus, pyloric, large intestine, duodenal stents, and stents for sample and study, among others. The Company’s stents are sold under the brand names of CHOOSTENT and HANAROSTENT. In addition, the Company is engaged in the manufacture and sale of low frequency therapies, crushers and blood glucose meters. The firm distributes its products within the domestic market and to overseas markets.

Frequently asked questions about MITech Co

Analysts currently set an average price target of 13,260.00 KRW for the MITech Co stock (median: 13,260.00 KRW), implying +186.1 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the MITech Co stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the MITech Co share trades at 3.08 EUR (4,635.00 KRW).

The revenue cannot currently be calculated for MITech Co.

The expected profit of MITech Co is 24.14 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of MITech Co is currently 6.22. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the MITech Co stock.

The P/S cannot be calculated for MITech Co currently.

The Eulerpool Quality Score for MITech Co is 6/10.

The ISIN of MITech Co is KR7179290002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of MITech Co is 179290.KQ. The ticker symbol is used to trade MITech Co shares on the stock exchange.

Fair ValueTerminal
4,913.10 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
479.66 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Nov 29, 2018
ISIN
KR7179290002
Cusip
Y604ND108
Market capitalization
149.93 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
6.21
P/Ee 2027
5.01
P/S
P/Se
—
EV/EBIT
7.25
P/B Ratio
1.19
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
16.15 %
Dividend
Dividend yield
2.16 %
Est. Dividend Yield
2.48 %
Payout Ratio
19.33 %
Dividend growth Ø5Y
4.56 %
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Oct 9, 2026, 4:25 PM

MITech Co Peer Group

MITech Co FIGI

179290:KS · BBG004D98K04179290:KQ · BBG00MBYYYL9

All fundamentals and in-depth analysis of MITech Co

Our stock analysis for MITech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MITech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.